Mealey's (October 17, 2018, 7:05 AM EDT) -- BATON ROUGE, La. — In a 3-2 decision, a Louisiana state appeals court on Oct. 3 vacated dismissal of the state attorney general’s lawsuit against Takeda Pharmaceuticals America Inc. and Eli Lilly and Co. for allegedly causing the state to pay for the diabetes drug Actos (pioglitazone) when the defendants knew that the drug carried a significant risk of bladder cancer (State of Louisiana, et al. v. Takeda Pharmaceuticals America, Inc., et al., No. 2017 CA 0498, La. App., 1st Cir., 2018 La. App. Unpub. LEXIS 275)....